Sequencing-based spatial analyses allow researchers to study the tumor microenvironment in situ and understand the dynamic relationship between the tumor and its microenvironment. Spatial genomics offers an unbiased view of cancer biology and true discovery power for drug targets and biomarkers.

Learn how three researchers are utilizing spatial profiling with NanoString’s GeoMx assays including the Cancer Transcriptome Atlas for Human and the Whole Transcriptome Atlas for Human and Mouse, combined with Illumina sequencing output to gain a deeper insight into their discovery research efforts.

Further your knowledge of:

  • The ways in which Spatial Genomics is advancing our understanding of tumor and tumor microenvironment
  • Insights gained from combining spatial interrogation with Next Generation Sequencing
  • How Spatial Genomics is impacting pathology

Jonathan Nowak, MD, PhD, of Brigham and Women’s Hospital highlights his ongoing work with the Human Cancer Transcriptome Atlas, Laura Attardi, PhD, of Stanford University will discuss her project featuring the Mouse Whole Transcriptome Atlas spatial profiling, and Gokul Das, PhD of the Roswell Park Comprehensive Cancer Center utilizes the Human Whole Transcriptome Atlas spatial profiling.

The event is co-hosted by Nanostring and Illumina.


Erin PIazza, PhD
Senior Bioinformatics Scientist
NanoString Technologies


Jonathan Nowak, MD, PhD
Pathologist and Assistant Professor of Pathology
Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School


Laura Attardi, PhD
Principal Investigator
Stanford University


Gokul Das, PhD
Associate Professor of Oncology
Roswell Park Comprehensive Cancer Center


Date & Time
28 Apr 2021
10:00 AM - 11:00 AM
North America
NanoString Technologies
Cancer research
Watch Now